Brain cell injection offers new hope for advanced Parkinson's patients
NCT ID NCT07550374
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a single injection of special brain cells (NouvNeu001) in 10 people with moderate-to-advanced Parkinson's who have already had deep brain stimulation surgery. The main goal is to check safety, but researchers will also track movement and daily function over 96 weeks. This is not a cure, but aims to better control symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of USTC
Hefei, Anhui, 230001, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill slow Parkinson's symptoms?
- Dancing away Parkinson's symptoms: tango therapy put to the test
- Gentle bowing, calmer mind: music therapy put to the test for Parkinson's anxiety
- Can a voice therapy program help turkish speakers with Parkinson's speak louder and clearer?
- Can a gene therapy rewire brain cells to ease Parkinson's?
- New sleep drug aims to help Parkinson's patients get a good Night's rest